CN1348778A - Chinese medicine prepn for treating AIDS, cancer, hepatitis, diabetes and angiopathy - Google Patents
Chinese medicine prepn for treating AIDS, cancer, hepatitis, diabetes and angiopathy Download PDFInfo
- Publication number
- CN1348778A CN1348778A CN00130131A CN00130131A CN1348778A CN 1348778 A CN1348778 A CN 1348778A CN 00130131 A CN00130131 A CN 00130131A CN 00130131 A CN00130131 A CN 00130131A CN 1348778 A CN1348778 A CN 1348778A
- Authority
- CN
- China
- Prior art keywords
- cancer
- parts
- hepatitis
- diabetes
- aids
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
The present invention discloses a pure Chinese medicine preparation for treating Aids, cancer, hepatitis, vascular disease, in particular, it can treat different tyres of Aids infection, liver cancer, lung cancer, stomach cancer, uterus cancer, intestine cancer, pyelopathy, kidney cancer, virus hepatitis A and B, arteriosclerosis, cardiomyopathy, stenosis, antisorhythmia, nephritis, urinemia, lockjaw, rheumatism, tuberculosis, immunity disease etc.
Description
The present invention relates to a kind of medicine for the treatment of acquired immune deficiency syndrome (AIDS), cancer, hepatitis, diabetes, angiopathy.Specifically with the Chinese patent medicine of Chinese herbal medicine preparation.The invention still further relates to preparation method.
Acquired immune deficiency syndrome (AIDS), cancer, hepatitis, angiopathy are the world's present five big difficult diseases.Both at home and abroad to the treatment of five kinds of diseases, following several shortcoming is arranged at present:
The medicine that in the world treatment of acquired immune deficiency syndrome (AIDS) is not also had radical cure at present, can only suppress virus replication, reduce viral load, postpone morbidity, chemicotherapy and the cancer pain hardship is controlled in operation and side effect is big, diabetes are by taking medicine all the life, the biguanide drug side effect is big, with producing antibody, the medicine of treatment angiopathy still leaves sequela through taking for a long time to insulin for a long time.Now with some Chinese medicine preparation are arranged, but all can only prolong life by mitigate the disease.
The purpose of this invention is to provide and a kind ofly kill HIV (human immunodeficiency virus) (Human Immunodeficiency Virus), reverse and swollenly to stay cell, kill hepatitis virus, endocrine regulation, the pure Chinese medicinal preparation of enhancing human body immunity function.
The preparation method that the purpose of this invention is to provide medicament in this.
Solution of the present invention is according to herbal nature in motherland's medical treasure-house and combination principle, selected blood circulation promoting and blood stasis dispelling, anti-inflammatory analgetic, strengthening the body resistance, the germ-resistant natural Chinese medicinal herb of detoxification, adjust immunity of organism, enhance metabolism, detoxicating element, blood stasis dispelling blood play kills HIV (human immunodeficiency virus) (Human Immunodeficiency Virus), the contagious effect of controller, the treatment cancer is to regulate human endocrine, and making tumour cell reversing is principle.Regulate metabolism disorder, promote islet secretion, realized the effect of medicine Zhiduo County disease.Can treat acquired immune deficiency syndrome (AIDS), cancer, hepatitis, diabetes.As hepatocarcinoma, pulmonary carcinoma, gastric cancer, uterus carcinoma, breast carcinoma, intestinal cancer, kidney
Cancer, bladder cancer, hepatitis A, hepatitis B, arteriosclerosis, coronary heart disease, angina pectoris, myocardium stalk, heart failure, arrhythmia, nephritis, uremia, puerperal exposure to wind, septicemia, tetanus, vitiligo, dermatosis, rheumatism, rheumatoid, pulmonary tuberculosis, bone tuberculosis, lymphoid tuberculosis, renal tuberculosis, tuberculosis of breast, immunological disease, infection disease, wound, infectious disease, flu, lobar pneumonia, nameless high fever, edema, inflammation, viral myocarditis, hypotension etc.
The present invention is made up of following component: (weight ratio)
Olibanum 10-15 Fen Zhu sand 10-12 part Herba Alii fistulosi 20-30 part
Myrrha 4-6 part Rhizoma Corydalis 5-8 part Fructus Luffae seed 10-14 part
Scorpio 2-4 part Magnetitum 10-12 part Semen Armeniacae Amarum 10-14 part
Scolopendra 2-4 part Mylabris 2-4 part Fructus Jujubae 40-60 part
Calomelas 4-6 part Borneolum Syntheticum 10-15 part
The formula optimization weight ratio scope of preparation medicine of the present invention is: (parts by weight)
Olibanum 8-10 Fen Zhu sand 8-10 part Herba Alii fistulosi 15-20 part
Myrrha 3-5 part Rhizoma Corydalis 5-8 part Fructus Luffae seed 8-12 part
Scorpio 2-4 part Magnetitum 8-10 part Semen Armeniacae Amarum 8-12 part
Scolopendra 2-4 part Mylabris 2-4 part Fructus Jujubae 30-50 part
Calomelas 3-5 part Borneolum Syntheticum 8-10 part
Optimum formula ratio of the present invention is: (parts by weight)
20 parts in 10 portions of Herba Alii fistulosis of Olibanum 10 Fen Zhu sand
12 parts of 8 parts of Fructus Luffae seeds of 5 parts of Rhizoma Corydalis of Myrrha
12 parts in 10 parts of Semen Armeniacae Amarums of 4 parts of Magnetitums of Scorpio
50 parts in 4 portions of Fructus Jujubaes of 4 portions of Mylabris of Scolopendra
10 parts of 5 parts of Borneolum Syntheticums of Calomelas
Above-mentioned each component is made medicine production method of the present invention:
1, gets Olibanum, Myrrha, Scorpio, Scolopendra, Calomelas, Zhu sand, Rhizoma Corydalis, Magnetitum, Mylabris, Borneolum Syntheticum, Fructus Luffae seed, Semen Armeniacae Amarum, pulverizing 120 order fineness earlier.
2, Herba Alii fistulosi, Fructus Jujubae are dried in the shade powder 120 order fineness.
3, will go up medicated powder and mix, measure and even bottling, sealing, every bottle of 10g with 1 times in 5 times of amounts of 60 degree hot water medicated powder.
Embodiment
One, take by weighing raw material by following proportioning:
20 kilograms in 10 kilograms of Herba Alii fistulosis of Olibanum 10 Qian Ke Zhu sand
12 kilograms of 8 kilograms of Fructus Luffae seeds of 5 kilograms of Rhizoma Corydalis of Myrrha
12 kilograms in 10 kilograms of Semen Armeniacae Amarums of 4 kilograms of Magnetitums of Scorpio
50 kilograms in 4 kilograms of Fructus Jujubaes of 4 kilograms of Mylabris of Scolopendra
10 kilograms of 5 kilograms of Borneolum Syntheticums of Calomelas
Claims (5)
1, a kind of treat acquired immune deficiency syndrome (AIDS), cancer, diabetes, vasculitis, phlebitis, tuberculosis, cardiovascular and cerebrovascular disease, sexually transmitted disease (STD), nephritis, medicine, its feature it be the medicament of making by the raw material of following weight ratio:
Olibanum 10-15 Fen Zhu sand 10-12 part Herba Alii fistulosi 20-30 part
Myrrha 4-6 part Rhizoma Corydalis 5-8 part Fructus Luffae seed 10-14 part
Scorpio 2-4 part Magnetitum 10-12 part Semen Armeniacae Amarum 10-14 part
Scolopendra 2-4 part Mylabris 2-4 part Fructus Jujubae 40-60 part
Calomelas 4-6 part Borneolum Syntheticum 10-15 part
2, according to the described treatment acquired immune deficiency syndrome (AIDS) of claim 1, cancer, diabetes, vasculitis, phlebitis, hepatitis, tuberculosis, cardiovascular and cerebrovascular disease, sexually transmitted disease (STD), nephritis, medicine, wherein the weight proportion of each raw material is:
Olibanum 8-10 Fen Zhu sand 8-10 part Herba Alii fistulosi 15-20 part
Myrrha 3-5 part Rhizoma Corydalis 5-8 part Fructus Luffae seed 8-12 part
Scorpio 2-4 part Magnetitum 8-10 part Semen Armeniacae Amarum 8-12 part
Scolopendra 2-4 part Mylabris 2-4 part Fructus Jujubae 30-50 part
Calomelas 3-5 part Borneolum Syntheticum 8-10 part
3, according to the medicine of the described treatment acquired immune deficiency syndrome (AIDS) of claim 1, cancer, diabetes, hepatitis, phlebitis, tuberculosis, cardiovascular and cerebrovascular disease, sexually transmitted disease (STD), nephritis wherein the best proportioning of each raw material weight be:
20 parts in 10 portions of Herba Alii fistulosis of Olibanum 10 Fen Zhu sand
12 parts of 8 parts of Semen Luffaes of 5 parts of Rhizoma Corydalis of Myrrha
12 parts in 10 parts of Semen Armeniacae Amarums of 4 parts of Magnetitums of Scorpio
50 parts in 4 portions of Fructus Jujubaes of 4 portions of Mylabris of Scolopendra
10 parts of 5 parts of Borneolum Syntheticums of Calomelas
4, according to claim 1,2 or 3 described treatment acquired immune deficiency syndrome (AIDS), cancer, diabetes, hepatitis, arteries and veins
The medicine of Guan Yan, phlebitis, tuberculosis, cardiovascular and cerebrovascular disease, sexually transmitted disease (STD), nephritis, it is characterized in that it is that a kind of special dosage form is heard agent on the pharmaceutics.
5, according to the medicine of the described treatment acquired immune deficiency syndrome (AIDS) of claim 4, cancer, diabetes, hepatitis, vasculitis, phlebitis, tuberculosis, cardiovascular and cerebrovascular disease, sexually transmitted disease (STD), nephritis.It is characterized in that getting Olibanum, Myrrha, Scorpio, Scolopendra, Calomelas, Borneolum Syntheticum, Mylabris, Magnetitum powder, Rhizoma Corydalis, Zhu sand, Fructus Luffae seed, Semen Armeniacae Amarum, clean, dry, pulverize 120 order fineness, Fructus Jujubae, Herba Alii fistulosi, air-dry, powder 120 orders and mix after, with 60 degree hot water, 5 times in water, 1 times in medicated powder and the sealing of sparing, bottle.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN00130131A CN1348778A (en) | 2000-10-17 | 2000-10-17 | Chinese medicine prepn for treating AIDS, cancer, hepatitis, diabetes and angiopathy |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN00130131A CN1348778A (en) | 2000-10-17 | 2000-10-17 | Chinese medicine prepn for treating AIDS, cancer, hepatitis, diabetes and angiopathy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1348778A true CN1348778A (en) | 2002-05-15 |
Family
ID=4593986
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN00130131A Pending CN1348778A (en) | 2000-10-17 | 2000-10-17 | Chinese medicine prepn for treating AIDS, cancer, hepatitis, diabetes and angiopathy |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1348778A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006131054A1 (en) * | 2005-06-04 | 2006-12-14 | Zichun Li | Chinese pharmaceutical ophthalmological formulations in forms of solutions, ointments and pills for antiaging recovery |
| CN101549064B (en) * | 2005-10-08 | 2011-11-09 | 河北以岭医药研究院有限公司 | Medicament composition containing chilopod acting on NEI network and uses thereof |
| CN103181945A (en) * | 2011-12-31 | 2013-07-03 | 江苏众红生物工程创药研究院有限公司 | Novel application of luffa seeds |
| CN103191170A (en) * | 2012-01-08 | 2013-07-10 | 江苏众红生物工程创药研究院有限公司 | Healthcare product for auxiliary treatment of type 2 diabetes, and preparation method thereof |
-
2000
- 2000-10-17 CN CN00130131A patent/CN1348778A/en active Pending
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006131054A1 (en) * | 2005-06-04 | 2006-12-14 | Zichun Li | Chinese pharmaceutical ophthalmological formulations in forms of solutions, ointments and pills for antiaging recovery |
| CN101549064B (en) * | 2005-10-08 | 2011-11-09 | 河北以岭医药研究院有限公司 | Medicament composition containing chilopod acting on NEI network and uses thereof |
| CN103181945A (en) * | 2011-12-31 | 2013-07-03 | 江苏众红生物工程创药研究院有限公司 | Novel application of luffa seeds |
| CN103181945B (en) * | 2011-12-31 | 2016-01-13 | 江苏众红生物工程创药研究院有限公司 | The purposes of Semen Luffae |
| CN103191170A (en) * | 2012-01-08 | 2013-07-10 | 江苏众红生物工程创药研究院有限公司 | Healthcare product for auxiliary treatment of type 2 diabetes, and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111097040A (en) | Antiviral lung-heat clearing peptide | |
| CN101703729B (en) | Chinese medicament for treating gastropathy | |
| CN1876053A (en) | A pharmaceutical used for moxibustion and preparation method thereof | |
| CN1772110A (en) | Chinese medicine composition | |
| CN104138570B (en) | A kind of Chinese medicine for the treatment of hepatopathy and preparation method thereof | |
| CN1348778A (en) | Chinese medicine prepn for treating AIDS, cancer, hepatitis, diabetes and angiopathy | |
| CN1082376C (en) | Pathogenic factor eliminating and healthy energy supporting anticancer medicine | |
| CN1208646A (en) | Medicine for treating gastrointestinal ulcer and gastritis | |
| CN102228648B (en) | Chinese medicinal composition for treating icterohepatitis | |
| CN104998137A (en) | Traditional Chinese medicine composite for treating lung diseases | |
| CN1059559C (en) | Oral medicine and external-use medicine for curing osteonosus and processing method thereof | |
| CN104873911B (en) | A kind of pyemic traditional Chinese medicine for oral administration of auxiliary treatment | |
| CN102614464A (en) | Traditional Chinese medicine composition for treating diabetic foot | |
| CN1264591A (en) | Medicine for treating psoriasis and preparing process thereof | |
| CN1302799C (en) | Oral Chinese medicinal composition for treating virus myocarditis | |
| CN1292275A (en) | Chinese medicine preparation for curing postpartum disease of woman | |
| CN1943700A (en) | A Chinese traditional medicinal preparation for treatment of eczema | |
| CN1074670C (en) | Medicine for the treatment of rheumatism and arthritis | |
| CN1219409A (en) | Traditional Chinese medicine for curing psoriasis | |
| CN101194940A (en) | Anti-inflammation medicament for treating toothache and preparation method thereof | |
| CN1823966A (en) | Medicine for treating aurigo | |
| CN1088801A (en) | Chinese patent medicine Jinguanpian tablets and the method for making thereof of treatment insensitive impediment, particularly RA and AS | |
| CN100339093C (en) | Compound medicine for treating coronary heart disease and angina pectoris and its preparing process | |
| CN1301724C (en) | Medicine for thrombotic diseases | |
| CN1973857A (en) | Chinese medicine red sage-astragalus root prepn for treating liver fibrosis and liver cirrhosis and its prepn process |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |